PMC:7377212 / 22593-23191
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 634 | 426-444 | Disease | denotes | Infectious Disease | MESH:D003141 |
| 635 | 547-580 | Disease | denotes | Infectious Diseases Aspergillosis | MESH:D003141 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T226 | 426-436 | Disease | denotes | Infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T227 | 464-477 | Disease | denotes | Aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
| T228 | 547-557 | Disease | denotes | Infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T229 | 567-580 | Disease | denotes | Aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T184 | 78-79 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T185 | 165-168 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T186 | 187-188 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T187 | 304-307 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T188 | 397-398 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T306 | 114-124 | Chemical | denotes | antifungal | http://purl.obolibrary.org/obo/CHEBI_35718 |
| T307 | 489-494 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T308 | 592-597 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T125 | 0-26 | Sentence | denotes | Conflict of interest: D.W. |
| T126 | 27-148 | Sentence | denotes | Denning and family hold founder shares in F2G Ltd, a University of Manchester spin-out antifungal discovery company; D.W. |
| T127 | 149-385 | Sentence | denotes | Denning acts or has recently acted as a consultant to Scynexis, Pulmatrix, Pulmocide, Zambon, iCo Therapeutics, Mayne Pharma, Biosergen, and Fujifilm; and has been paid for talks on behalf of Hikma, Gilead, Merck, Mylan and Pfizer; D.W. |
| T128 | 386-598 | Sentence | denotes | Denning is a longstanding member of the Infectious Disease Society of America Aspergillosis Guidelines group, the European Society for Clinical Microbiology and Infectious Diseases Aspergillosis Guidelines group. |